Inogen (INGN) Common Equity (2012 - 2026)
Inogen (INGN) posted quarterly Common Equity of $182.9 million for Q1 2026, down 7.6% year-over-year from $198.0 million in Q1 2025, and down 4.85% quarter-over-quarter from $192.2 million in Q4 2025.
Inogen (INGN) Common Equity (2012 - 2026) Analysis & Trends
Inogen (INGN) has reported Common Equity for 15 consecutive years, with $182.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Common Equity fell 7.6% year-over-year to $182.9 million; the TTM figure through Mar 2026 stood at $182.9 million (down 7.6% YoY), while the FY2025 annual figure was $192.2 million, up 10.57% from the prior year.
- Common Equity slipped to $182.9 million in Q1 2026 per INGN's latest filing, from $192.2 million in the prior quarter.
- Across five years, Common Equity topped out at $358.3 million in Q1 2022 and bottomed at $173.9 million in Q4 2024.
- Historically, Common Equity has averaged $239.0 million across 5 years, with a median of $199.5 million in 2025.
- Annual changes were most pronounced in 2023 — Common Equity sank 34.26% — and 2025, when it grew 10.57%.
- Inogen's Common Equity stood at $297.4 million in 2022, then plunged by 31.13% to $204.8 million in 2023, then declined by 15.11% to $173.9 million in 2024, then advanced by 10.57% to $192.2 million in 2025, then declined by 4.85% to $182.9 million in 2026.
- Business Quant data shows INGN's Common Equity at $182.9 million in Q1 2026, $192.2 million in Q4 2025, and $197.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 51.76 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 23.99 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 50.07 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 25.17 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 10.72 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 2.62 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 10.99 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 13.31 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 7.22 Bn |
| 10 | Inogen | 151.72 Mn | 46.18 Mn | 43.27 Mn | 174.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 174.86 Mn |
| Mar 31, 2026 | 182.91 Mn |
| Dec 31, 2025 | 192.23 Mn |
| Sep 30, 2025 | 197.18 Mn |
| Jun 30, 2025 | 199.49 Mn |
| Mar 31, 2025 | 197.95 Mn |
| Dec 31, 2024 | 173.86 Mn |
| Sep 30, 2024 | 185.40 Mn |
| Jun 30, 2024 | 187.60 Mn |
| Mar 31, 2024 | 191.90 Mn |
| Dec 31, 2023 | 204.81 Mn |
| Sep 30, 2023 | 230.63 Mn |
| Jun 30, 2023 | 274.78 Mn |
| Mar 31, 2023 | 281.30 Mn |
| Dec 31, 2022 | 297.41 Mn |
| Sep 30, 2022 | 350.84 Mn |
| Jun 30, 2022 | 356.54 Mn |
| Mar 31, 2022 | 358.29 Mn |
| Dec 31, 2021 | 370.23 Mn |
| Sep 30, 2021 | 390.92 Mn |